Brief: Shanghai Junshi Biosciences Says Singapore Health Sciences Authority Accepted New Drug Application Of Toripalimab
01/02/2024 15:16
Feb 1 (Reuters) - Shanghai Junshi Biosciences Co Ltd
688180.SS :
* SINGAPORE HEALTH SCIENCES AUTHORITY ACCEPTED NEW DRUG
APPLICATION OF TORIPALIMAB
Source text for Eikon: ID:n11058404-1
Further company coverage: 688180.SS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shanghai Junshi Biosciences
See all newsBrief: Shanghai Junshi Biosciences Q3 Net Loss At 170.9 Million Yuan
Brief: Shanghai Junshi Biosciences Q3 Net Loss At 170.9 Million Yuan
Brief: Shanghai Junshi Biosciences Receives Supplemental Drug Approval From NMPA
Brief: Shanghai Junshi Biosciences's Shareholder Plans To Cut Stake
Brief: Shanghai Junshi Biosciences Gets NMPA Acceptance Notice Of Supplemental Application For Toripalimab